Supreme Cannabis Expands International Medical Cannabis Shipments

Supreme Cannabis Completes its First Shipment of Medical Cannabis to Australia and Fourth Shipment of Medical Cannabis to Israel

TORONTO, Jan. 8, 2021 /PRNewswire/ – The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that it has made its first shipment of medical cannabis to Australia in a private label transaction in which the Company’s medical cannabis will be sold in 10-gram containers and will be distributed to patients across the country.

The Australian medical cannabis market was characterized by strong year-over-year growth in 2020. According to FreshLeaf Analytics’ Australian Medicinal Cannabis Market Patient and Pricing Analysis for Q3 2020, the Australian medical cannabis market is expected to triple with regards to active patients and product sales measured by revenue.

The Company also completed its fourth shipment of calendar 2020 to Israel through the Company’s partnership with Breath of Life International Ltd. (“BOL Pharma”), Israel’s largest and leading producer of medical cannabis and cannabis products. This shipment was the largest to date of Jean Guy and Sensi Star strains, sold under the Truverra label.

“We are pleased to be introducing our medical cannabis to the Australian market,” said Beena Goldenberg, President and CEO of Supreme Cannabis. “Having already completed shipments to Israel, our first sale into the Australian market is a meaningful step toward executing on our international medical strategy of creating additional wholesale medical partnerships in various international jurisdictions. We are committed to supplying high-quality medical cannabis to our partners; Australian patients will now be able to access our Jean Guy strain, which is a tribute to the legendary variety offered by the Montreal Compassion Club. We are impressed by the significant growth of the Australian medical cannabis market and we look forward to opportunities to expand our Australian partnership and help more Australian patients in 2021.”

About Supreme Cannabis.

The Supreme Cannabis Company, Inc., (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the Company has emerged as one of the world’s most premium producers of recreational, wholesale and medical cannabis products.

Supreme Cannabis’ portfolio of brands caters to diverse consumer and patient experiences, with brands and products that address recreational, wellness, medical and new consumer preferences. The Company’s recreational brand portfolio includes, 7ACRES7ACRES Craft CollectiveBlisscosugarleaf, and Hiway. Supreme Cannabis addresses national and international medical cannabis opportunities through its premium Truverra brand.

Supreme Cannabis’ brands are backed by a focused suite of world-class operating assets that serve key functions in the value chain, including, scaled cultivation, value-add processing, automated packaging and product testing and R&D. Follow the Company on InstagramTwitterFacebookLinkedIn and YouTube.

We simply grow better.

Forward-Looking Information. 

Certain statements made in this press release constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking information may relate to anticipated events or results and other statements that are not historical facts. The forward-looking information is based on assumptions and estimates that the Company believes are appropriate and reasonable in the circumstances. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including risks regarding the COVID-19 epidemic, the cannabis industry, market conditions, economic factors, management’s ability to manage and to operate the business and the equity markets generally. The forward-looking information contained in this press release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. 

SOURCE NEWSWIRE